Skip to main content

Journals in Infectious diseases and chemotherapy

American Journal of Infection Control

  • ISSN: 0196-6553
  • 5 Year impact factor: 3.1
  • Impact factor: 3.8
The Official Publication of the Association for Professionals in Infection Control and Epidemiology, Inc.AJIC covers key topics and issues in infection control and epidemiology. Infection control professionals, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC). AJIC is the foremost resource on infection control, epidemiology, infectious diseases, quality management, occupational health, and disease prevention. AJIC also publishes infection control guidelines from APIC and the CDC. AJIC is included in Index Medicus and CINAHL.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
American Journal of Infection Control

Antiviral Research

  • ISSN: 0166-3542
  • 5 Year impact factor: 5
  • Impact factor: 4.5
Antiviral Research aims to publish manuscripts in the field of prevention and treatment of viral diseases in humans and vertebrate animals, and encourages authors to the submit manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases. The journal is an Official Publication of the International Society for Antiviral Research. The types of papers published in Antiviral Research includes original research reports, short communications, commentaries and invited review* articles on the control of viral infections in humans. The journal’s scope encompasses:antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.identification and validation of new drug targets;laboratory animal models of viral diseases for antiviral efficacy testing;evolution of drug-resistant viruses and the development of effective counter measures;pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses;assessments of drug safety;new or improved vaccines against viral infections of humans; the prevention and treatment of viral diseases of vertebrate animals, and reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis that must be clearly described in the manuscript.Antiviral Research journal does not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We discourage the submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."ISAR members Authors who are ISAR members are encouraged to contact ISAR after their paper has been accepted for publication in order to benefit from their published work being highlighted in ISAR postings on their social media platforms (further details on this will be given in the AVR acceptance letter). *Antiviral Research journal has started a new initiative to publish at least two thematic special issues per year, containing invited reviews in addition to the ad hoc invitations to experts in the areas within the scope of the journal.
Antiviral Research

Clinical Microbiology Newsletter

  • ISSN: 0196-4399
Clinical Microbiology Newsletter is published bi-monthly to to provide consistent educational features and to keep pace with advances in the fast-moving field of Clinical Microbiology.Clinical Microbiology Newsletter aims to provide articles to enable you to streamline procedures and improve results. It publishes reviews on infectious disease pathogens, reports on changes that affect your work, including articles on new diagnostic techniques, regulatory and guideline changes, and challenging diagnostic dogmas, clinical cases focused on diagnostic approaches for both common and uncommon pathogens.The journal publishes three types of articles:Mini-reviews Case presentationsMicrobe SnapshotsThese articles cover topics including:Minireviews on the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of infectious diseases,Practical articles on common and contemporary laboratory techniques,Indispensable updates on important clinical problems that impact the clinical laboratory,Editorials and opinions on controversial issues in laboratory medicine,Case-based articles focused on diagnostic approaches for infectious pathogens,Snapshots highlighting specific infectious pathogens,Helpful tips on improving the laboratory workplace.
Clinical Microbiology Newsletter

Diagnostic Microbiology and Infectious Disease

  • ISSN: 0732-8893
  • 5 Year impact factor: 2
  • Impact factor: 2.1
Diagnostic Microbiology and Infectious Disease provides up to date and extensive articles on clinical microbiology.Diagnostic Microbiology and Infectious Disease aims to publish latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. It publishes articles on studies in bacteriology, immunology, immunoserology.Submissions on new procedures, unusual cases, controversial issues, and important new literature. are particularly welcomed.The journal publishes topics including:Informed commentaries on new antibioticsRapid and cost-effective methods in the laboratoryInstructive case studies with emphasis on complex circumstancesInsightful editorials on important current issuesBook reviews that keep you up-to-date on recently published literatureLaboratory and clinical management of microbial diseasesEpidemiology and pathogenesis of infectionsAutomation in the diagnostic microbiology laboratoryAntibiotic susceptibility testing
Diagnostic Microbiology and Infectious Disease

Infectious Disease Clinics of North America

  • ISSN: 0891-5520
  • 5 Year impact factor: 6.3
  • Impact factor: 6.1
Infectious Disease Clinics of North America updates you on the latest trends in the clinical diagnosis and management of patients with infectious diseases, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in infectious disease, including clinical microbiology, compromised host infections, gastrointestinal infections, global health, hepatitis, HIV/AIDS, hospital-acquired infections, travel medicine, infection control, bacterial infections, sexually transmitted diseases, urinary tract infections, and viral infections. Infectious Disease Clinics of North America is published four times each year, March, June, September, and December.
Infectious Disease Clinics of North America

Journal of Clinical Virology

  • ISSN: 1386-6532
  • 5 Year impact factor: 4
  • Impact factor: 4
Journal of Clinical Virology is an international journal and is the Official journal of the Pan American Society for Clinical Virology and The European Society for Clinical Virology.Journal of Clinical Virology aims to publish papers and reviews on the clinical aspects of human virology. It publishes articles on diagnostical methods and virus-induced clinical conditions. The manuscripts should be clinically practical and relevant.Submissions on new technologies for viral diagnosis and monitoring are particularly welcomed.The journal publishes on topics that include:• new diagnostic technologies • nucleic acid amplification and serologic testing • targeted and metagenomic next-generation sequencing • emerging pandemic viral threats • respiratory viruses • transplant viruses • chronic viral infections • cancer-associated viruses • gastrointestinal viruses • central nervous system viruses • one health (excludes animal health)Journal of Clinical Virology does not accept submissions on single cases or case series. Please submit manuscripts of this type to IDcases. Journal of Clinical Virology also does not accept submissions on fundamental virology. Please submit manuscripts of this type to Virology.
Journal of Clinical Virology

Journal of Hospital Infection

  • ISSN: 0195-6701
  • 5 Year impact factor: 3.9
  • Impact factor: 3.9
An Official Journal of the Healthcare Infection SocietyThe Journal of Hospital Infection is the editorially independent scientific publication of the Healthcare Infection Society. The aim of the Journal is to publish high quality research and information relating to infection prevention and control that is relevant to an international audience.The Journal welcomes submissions that relate to all aspects of infection prevention and control in healthcare settings. This includes submissions that:provide new insight into the epidemiology, surveillance, or prevention and control of healthcare-associated infections and antimicrobial resistance in healthcare settings;provide new insight into cleaning, disinfection and decontamination;provide new insight into the design of healthcare premises;describe novel aspects of outbreaks of infection;throw light on techniques for effective antimicrobial stewardship;describe novel techniques (laboratory-based or point of care) for the detection of infection or antimicrobial resistance in the healthcare setting, particularly if these can be used to facilitate infection prevention and control;improve understanding of the motivations of safe healthcare behaviour, or describe techniques for achieving behavioural and cultural change;improve understanding of the use of IT systems in infection surveillance and prevention and control.We also welcome submissions that relate to national policies or guidelines, especially where the subject matter is of international relevance.Although our readership is predominantly clinical, we are also pleased to receive basic science submissions that have clinical relevance.The Journal's open access companion title, Infection Prevention in Practice, welcomes a range of submissions providing practical information to healthcare professionals working in infection prevention and control.
Journal of Hospital Infection

Microbial Pathogenesis

  • ISSN: 0882-4010
  • 5 Year impact factor: 3.6
  • Impact factor: 3.3
Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.Research Areas Include:PathogenesisVirulence factorsHost susceptibility or resistanceImmune mechanismsIdentification, cloning and sequencing of relevant genesGenetic studiesViruses, prokaryotic organisms and protozoaMicrobiotaSystems biology related to infectious diseasesTargets for vaccine design (pre-clinical studies)The journal aims for rapid publication of articles of high quality and significance in an international forum. Please note that reviews are only accepted upon editorial invitation.Microbial Pathogenesis does not accept submissions that primarily consist of (a) bioinformatics or computational analysis of public genomic or transcriptomic databases, or (b) the testing and evaluation of previously uncharacterized natural product-based drug candidates. The journal does not publish purely bioinformatic or computational studies without substantial experimental validation. Please be aware that experimental validation is a mandatory requirement for all submissions.
Microbial Pathogenesis

Parasitology International

  • ISSN: 1383-5769
  • 5 Year impact factor: 1.6
  • Impact factor: 1.5
The Official, International Journal of the Japanese Society of ParasitologyParasitology International provides a medium for rapid, carefully reviewed publications in the field of human and animal parasitology. Original papers, rapid communications, and original case reports from all geographical areas and covering all parasitological disciplines, including structure, immunology, cell biology, biochemistry, molecular biology, and systematics, may be submitted. Reviews on recent developments are invited regularly, but suggestions in this respect are welcome. Letters to the Editor commenting on any aspect of the Journal are also welcome.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Parasitology International

The Lancet Infectious Diseases

  • ISSN: 1473-3099
  • 5 Year impact factor: 32.4
  • Impact factor: 36.4
The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide.As the global leader in clinical infectious diseases, The Lancet Infectious Diseases delivers essential original research, expert review, candid commentary, and breaking news to provide context and perspective on today's most important medical advances across the broad spectrum of clinical infectious diseases.
The Lancet Infectious Diseases